Wixela Inhub Coupons & Savings Card – Discount Prices from $58.95

Wixela and Advair are not the same, but they are similar. Both are combination inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). They contain the same active ingredients: fluticasone propionate, a corticosteroid, and salmeterol, a long-acting beta-agonist. However, Wixela is a generic version of Advair Diskus, which means it is therapeutically equivalent but may differ in inactive ingredients or device design.

Wixela Inhub is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps to control and prevent symptoms such as wheezing and shortness of breath.

Yes, Wixela is an inhaled medication that contains a combination of fluticasone propionate, which is a corticosteroid, and salmeterol, a long-acting beta-agonist. The fluticasone component acts as an inhaled steroid to help reduce inflammation in the airways.

Wixela should not be used by individuals who have a severe allergy to milk proteins, as the product contains lactose. Additionally, it is not recommended for those with a known hypersensitivity to fluticasone propionate, salmeterol, or any other ingredients in the formulation. Patients with acute episodes of asthma or COPD requiring intensive measures should not use Wixela as it is not intended for relief of acute symptoms. It is also important for individuals with certain medical conditions, such as severe cardiovascular disorders, to consult their healthcare provider before using Wixela.

Yes, the Wixela inhaler contains steroids. It includes fluticasone propionate, which is a corticosteroid, and salmeterol, a long-acting beta-agonist. The fluticasone component helps to reduce inflammation in the airways.